PTEN and neoplasm: For instance, mutations in the phosphatase and tensin homolog (PTEN) gene, which are prevalent in TNBC, can lead to the activation of the phosphoinositide 3-kinase (PI3K) pathway, promoting tumor growth and survival, while simultaneously suppressing anti-tumor immunity [135].